Skip to main content
hello world

Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)

AI-generated - The Globe and Mail - Sun Sep 29, 8:02PM CDT

Valeo Pharma is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
VPHValeo Pharma0.050.180.13 (251.5%)617134.90.00.0
ENTGEntourage Health0.010.030.02 (225.9%)280663.10.00.0
DBDecibel Cannabis Co0.060.140.08 (151.0%)16019423.00.00.0
LFSTLifeist Wellness0.090.210.12 (135.2%)279212.60.00.0
AVNTAvant Brands1.062.391.33 (125.1%)737810.00.00.0
CANBCanadaBis Cap0.060.130.07 (124.5%)352078.30.03.0
XLYAuxly Cannabis Group0.040.070.03 (90.3%)28359845.60.00.0
TSNDTerrAscend1.793.171.38 (77.1%)100117521.80.00.0
CWEBCharlottes Web Holdings0.190.330.14 (73.4%)3525929.90.00.0
CRONCronos Group2.924.871.95 (66.7%)1159781115.90.00.0

All data provided as of September 30, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Valeo Pharma

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Valeo Pharma is listed under VPH on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.